NO20081622L - Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser - Google Patents

Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser

Info

Publication number: NO20081622L
Authority: NO; Norway
Prior art keywords: methods; cell culture; producing proteins; antigenesis; compound
Prior art date: 2005-10-24

Application number

NO20081622A

Other languages

English (en)

Norwegian (no)

Inventor

Denis Drapeau

Wenge Wang

Yen-Tung Luan

Paul Thoday

Judy Chou

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-24

Filing date

2008-04-02

Publication date

2008-06-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081622(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-04-02 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-06-18 Publication of NO20081622L publication Critical patent/NO20081622L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Pyridine Compounds (AREA)

NO20081622A 2005-10-24 2008-04-02 Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser NO20081622L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72957305P	2005-10-24	2005-10-24
PCT/US2006/041256 WO2007050498A2 (en)	2005-10-24	2006-10-24	Methods of protein production using anti-senescence compounds

Publications (1)

Publication Number	Publication Date
NO20081622L true NO20081622L (no)	2008-06-18

Family

ID=37873105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081622A NO20081622L (no)	2005-10-24	2008-04-02	Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser

Country Status (23)

Country	Link
US (1)	US20070110743A1 (pl)
EP (1)	EP1941026B1 (pl)
JP (2)	JP2009512459A (pl)
KR (1)	KR101402634B1 (pl)
CN (1)	CN101297027B (pl)
AR (1)	AR058140A1 (pl)
AU (1)	AU2006306433B2 (pl)
BR (1)	BRPI0617744A2 (pl)
CA (1)	CA2627003C (pl)
CR (1)	CR9897A (pl)
DK (1)	DK1941026T3 (pl)
EC (1)	ECSP088395A (pl)
ES (1)	ES2485374T3 (pl)
IL (1)	IL190550A (pl)
NI (1)	NI200800111A (pl)
NO (1)	NO20081622L (pl)
PE (1)	PE20070796A1 (pl)
PL (1)	PL1941026T3 (pl)
PT (1)	PT1941026E (pl)
RU (1)	RU2491347C2 (pl)
SI (1)	SI1941026T1 (pl)
TW (1)	TW200736397A (pl)
WO (1)	WO2007050498A2 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2041270T3 (da)	2006-07-13	2014-01-27	Wyeth Llc	Fremstilling af glycoproteiner
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
CA2842964A1 (en)	2006-09-13	2008-03-20	Abbvie Inc.	Cell culture improvements
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
NZ592095A (en)	2008-10-20	2013-01-25	Abbott Lab	Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
AU2009307737B2 (en)	2008-10-20	2015-07-23	Abbvie Inc.	Viral inactivation during purification of antibodies
EP2464739B1 (en)	2009-08-14	2016-01-13	Basf Se	Methods in cell cultures, and related inventions, employing certain additives
EP2601287B1 (en)	2010-08-05	2015-01-07	Amgen Inc.	Dipeptides to enhance yield and viability from cell cultures
SG187885A1 (en) *	2010-08-31	2013-03-28	Friesland Brands Bv	Culture medium for eukaryotic cells
US9062106B2 (en)	2011-04-27	2015-06-23	Abbvie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TW201247874A (en) *	2011-05-25	2012-12-01	United Biomedical Inc	Method for producing the activity of bone activating protein
US9150645B2 (en)	2012-04-20	2015-10-06	Abbvie, Inc.	Cell culture methods to reduce acidic species
US9181572B2 (en)	2012-04-20	2015-11-10	Abbvie, Inc.	Methods to modulate lysine variant distribution
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
EP2890782A1 (en)	2012-09-02	2015-07-08	AbbVie Inc.	Methods to control protein heterogeneity
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
HK1207960A1 (en)	2013-03-12	2016-02-19	Abbvie Inc.	Human antibodies that bind human tnf-alpha and methods of preparing the same
CA2902938C (en) *	2013-03-13	2021-06-01	Neocutis Sa	Peptides for skin rejuvenation and methods of using the same
WO2014151878A2 (en)	2013-03-14	2014-09-25	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
BR112015021993A8 (pt)	2013-03-15	2019-12-03	Genentech Inc	polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CN106170298B (zh)	2013-10-16	2024-01-09	前瞻疗法公司	用于提高抗体稳定性的缓冲液制剂
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CN104398398A (zh) *	2014-10-27	2015-03-11	陈少威	一种细胞量子动力素(平衡剂)及其使用方法
MA40864A (fr) *	2014-10-31	2017-09-05	Biogen Ma Inc	Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
US10696735B2 (en)	2015-01-21	2020-06-30	Outlook Therapeutics, Inc.	Modulation of charge variants in a monoclonal antibody composition
TW202440903A (zh)	2015-08-04	2024-10-16	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法（一）
WO2017083224A1 (en) *	2015-11-09	2017-05-18	Bristol-Myers Squibb Company	Methods to manipulate quality attributes of polypeptides produced in cho cells
CA3010600A1 (en) *	2016-01-06	2017-07-13	Oncobiologics, Inc.	Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition
MX2018009341A (es)	2016-02-03	2019-05-15	Oncobiologics Inc	Formulaciones tamponadas para una mayor estabilidad de anticuerpos.
KR20240149973A (ko) *	2017-10-16	2024-10-15	리제너론 파마슈티칼스 인코포레이티드	세포 배양에서 공정 변수를 제어하기 위한 원위치 라만 분광법 시스템 및 방법
US12297451B1 (en)	2019-10-25	2025-05-13	Regeneron Pharmaceuticals, Inc.	Cell culture medium
WO2025053166A1 (ja) *	2023-09-05	2025-03-13	味の素株式会社	培地組成物
TW202536166A (zh) *	2023-12-25	2025-09-16	日商武田藥品工業股份有限公司	細胞的培養方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5225539A (en) *	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
DE10399023I2 (de) *	1989-09-12	2006-11-23	Ahp Mfg B V	TFN-bindende Proteine
US5859205A (en) *	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
WO1992009298A1 (en)	1990-11-23	1992-06-11	Peptide Technology Ltd.	The delay, prevention and/or reversal of cell senescence
EP0940468A1 (en) *	1991-06-14	1999-09-08	Genentech, Inc.	Humanized antibody variable domain
RU2245365C2 (ru) *	1994-01-03	2005-01-27	Генентек Инк.	Тромбопоэтин
US5830761A (en) *	1995-06-07	1998-11-03	Genetics Institute, Inc.	Medium and methods for culturing mammalian cho cells
RU2134120C1 (ru) *	1995-06-26	1999-08-10	Безруков Михаил Васильевич	Средство для стабилизации пептидной связи в белковом препарате
ES2176484T3 (es) *	1995-08-18	2002-12-01	Morphosys Ag	Bancos de proteinas/(poli)peptidos.
JP4306813B2 (ja) *	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US6146847A (en) *	1996-11-01	2000-11-14	Genespan Corporation	Stabilized transient gene expression
EP1500329B1 (en) *	1996-12-03	2012-03-21	Amgen Fremont Inc.	Human antibodies that specifically bind human TNF alpha
US20030040095A1 (en) *	2001-03-16	2003-02-27	Achille Arini	Method for the production of pharmaceutically active recombinant proteins
MXPA03009626A (es) *	2001-04-24	2004-06-30	Innogenetics Nv	Construcciones y metodo para la expresion de proteinas recombinantes de la envoltura viral de hcv.
JP4541157B2 (ja) *	2002-12-23	2010-09-08	ブリストル−マイヤーズスクイブカンパニー	タンパク質を製造するための哺乳類細胞培養法
KR101221862B1 (ko) *	2003-10-27	2013-01-14	와이어쓰 엘엘씨	하이드록시아파타이트 크로마토그래피를 사용한 고분자량응집체의 제거
WO2005064013A1 (en)	2003-12-23	2005-07-14	Bart Janssen	The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy
TWI364458B (en) *	2004-08-27	2012-05-21	Wyeth Res Ireland Ltd	Production of tnfr-lg
TWI384069B (zh) *	2004-08-27	2013-02-01	Pfizer Ireland Pharmaceuticals	多胜肽之製法
US7335491B2 (en) *	2004-08-27	2008-02-26	Wyeth Research Ireland Limited	Production of anti-abeta
US7426440B2 (en) *	2004-09-24	2008-09-16	Nutritional Bioscience Ltd.	Repair and protection factor scoring method for bioactive agents

2006
- 2006-10-23 AR ARP060104624A patent/AR058140A1/es unknown
- 2006-10-23 PE PE2006001284A patent/PE20070796A1/es not_active Application Discontinuation
- 2006-10-24 EP EP06844211.0A patent/EP1941026B1/en active Active
- 2006-10-24 PT PT68442110T patent/PT1941026E/pt unknown
- 2006-10-24 DK DK06844211.0T patent/DK1941026T3/da active
- 2006-10-24 SI SI200631796T patent/SI1941026T1/sl unknown
- 2006-10-24 CN CN2006800396267A patent/CN101297027B/zh not_active Expired - Fee Related
- 2006-10-24 KR KR1020087009856A patent/KR101402634B1/ko not_active Expired - Fee Related
- 2006-10-24 TW TW095139179A patent/TW200736397A/zh unknown
- 2006-10-24 PL PL06844211T patent/PL1941026T3/pl unknown
- 2006-10-24 WO PCT/US2006/041256 patent/WO2007050498A2/en not_active Ceased
- 2006-10-24 AU AU2006306433A patent/AU2006306433B2/en not_active Ceased
- 2006-10-24 ES ES06844211.0T patent/ES2485374T3/es active Active
- 2006-10-24 US US11/585,607 patent/US20070110743A1/en not_active Abandoned
- 2006-10-24 BR BRPI0617744-1A patent/BRPI0617744A2/pt not_active Application Discontinuation
- 2006-10-24 CA CA2627003A patent/CA2627003C/en active Active
- 2006-10-24 RU RU2008113220/10A patent/RU2491347C2/ru active
- 2006-10-24 JP JP2008537834A patent/JP2009512459A/ja not_active Withdrawn
2008
- 2008-04-01 IL IL190550A patent/IL190550A/en active IP Right Grant
- 2008-04-02 NO NO20081622A patent/NO20081622L/no not_active Application Discontinuation
- 2008-04-09 NI NI200800111A patent/NI200800111A/es unknown
- 2008-04-18 CR CR9897A patent/CR9897A/es not_active Application Discontinuation
- 2008-04-23 EC EC2008008395A patent/ECSP088395A/es unknown
2013
- 2013-04-26 JP JP2013094315A patent/JP5907928B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NI200800111A (es)	2009-03-03
SI1941026T1 (sl)	2014-07-31
JP5907928B2 (ja)	2016-04-26
IL190550A0 (en)	2008-11-03
CN101297027A (zh)	2008-10-29
TW200736397A (en)	2007-10-01
ECSP088395A (es)	2008-05-30
IL190550A (en)	2017-01-31
US20070110743A1 (en)	2007-05-17
EP1941026B1 (en)	2014-06-04
KR20080063365A (ko)	2008-07-03
BRPI0617744A2 (pt)	2011-08-02
AU2006306433A1 (en)	2007-05-03
AR058140A1 (es)	2008-01-23
CN101297027B (zh)	2013-04-03
JP2013165728A (ja)	2013-08-29
PE20070796A1 (es)	2007-08-15
PT1941026E (pt)	2014-07-31
DK1941026T3 (da)	2014-07-21
WO2007050498A3 (en)	2007-07-12
CR9897A (es)	2008-07-29
RU2491347C2 (ru)	2013-08-27
JP2009512459A (ja)	2009-03-26
HK1120552A1 (en)	2009-04-03
PL1941026T3 (pl)	2014-12-31
CA2627003C (en)	2018-08-28
ES2485374T3 (es)	2014-08-13
CA2627003A1 (en)	2007-05-03
RU2008113220A (ru)	2009-12-10
WO2007050498A2 (en)	2007-05-03
KR101402634B1 (ko)	2014-06-03
AU2006306433B2 (en)	2013-04-18
EP1941026A2 (en)	2008-07-09

Publication	Publication Date	Title
NO20081622L (no)	2008-06-18	Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser
MX2009011363A (es)	2009-11-05	Metodo de produccion de proteinas utilizando compuestos anti-senectud.
DK1623023T3 (da)	2009-03-02	Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
EA200870204A1 (ru)	2009-04-28	Системы и способы производства биотоплива и связанных с этим материалов
WO2011133902A3 (en)	2012-04-19	Cell culture medium comprising small peptides
MX344970B (es)	2017-01-12	Medio de cultivo celular para la expresion de la proteina adamts.
WO2008060541A3 (en)	2008-08-28	In vitro expansion of postpartum-derived cells using microcarriers
EP3486314A3 (en)	2019-08-07	Placental stem cell populations
NO20072719L (no)	2007-05-29	Serumfritt cellekulturmedium for pattedyrceller
BRPI0513837A (pt)	2008-05-20	células hospedeiras geneticamente modificadas e uso das mesmas para produzir compostos isoprenóides
SG149061A1 (en)	2009-01-29	Definitive endoderm
SG152273A1 (en)	2009-05-29	Pdx1 expressing endoderm
EP4368701A3 (en)	2024-09-04	Feeder-free culture system
NO20071619L (no)	2007-04-25	Fremgangsmate for fremstilling av indazol forbindelse
WO2009145419A9 (ko)	2010-03-11	식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
WO2004090096A3 (en)	2005-03-03	Methods for neural differentiation of embryonic stem cells using protease passaging techniques
AU2019268061A1 (en)	2019-12-12	Placental stem cell populations
WO2010020876A3 (en)	2010-04-15	Cell culture method to form aggregates
DE60307615D1 (de)	2006-09-28	Zellkulturmedium
NO20061470L (no)	2006-05-12	Fremgangsmate for fremstilling av gamma-karboksylerte proteiner
EA201170025A1 (ru)	2011-08-30	Способы повышения жизнеспособности и продукции культуры клеток
CY1112746T1 (el)	2016-02-10	Κρυοσυντηρηση ηπατοκυτταρων
WO2007016366A3 (en)	2009-04-30	Defined culture conditions of human embryonic stem cells
WO2008090148A3 (en)	2008-09-18	Improvement of cell growth
ZA202107808B (en)	2024-11-27	Cell culture medium for eukaryotic cells

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application